Dmitry Tworowski

Dr. Dmitry Tworowski


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2011 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
MGMoran Grossman
Moran Grossman
BBBenjamin Born
Benjamin Born
MHMatthias Heyden
Matthias Heyden
DTDmitry Tworowski
Dmitry Tworowski
GFGregg B Fields
Gregg B Fields
MHMartina Havenith
Martina Havenith

1 December 2005 in Structure
Verified
Journal Article
Closed access
OKOlga Kotik-Kogan
Olga Kotik-Kogan
NMNina Moor
Nina Moor
DTDmitry Tworowski
Dmitry Tworowski
MSMark Safro
Mark Safro

1 October 2008 in Phytochemistry
Verified
Journal Article
Closed access
KLKristin C. Lewis
Kristin C. Lewis
TSTzvia Selzer
Tzvia Selzer
CSChen Shahar
Chen Shahar
YUYael Udi
Yael Udi
DTDmitry Tworowski
Dmitry Tworowski
ISIrit Sagi
Irit Sagi

29 June 2010 in Biochemistry
Verified
Journal Article
Closed access
MGMoran Grossman
Moran Grossman
DTDmitry Tworowski
Dmitry Tworowski
ODOrly Dym
Orly Dym
MLMeng-Huee Lee
Meng-Huee Lee
YLYaakov Levy
Yaakov Levy
ISIrit Sagi
Irit Sagi

9 June 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
Sumit MukherjeeSumit Mukherjee
Sumit Mukherjee
DTDmitry Tworowski
Dmitry Tworowski
RDRajesh Detroja
Rajesh Detroja
SMSunanda Biswas Mukherjee
Sunanda Biswas Mukherjee
Milana Frenkel-MorgensternMilana Frenkel-Morgenstern
Milana Frenkel-Morgenstern
A new coronavirus infection, COVID-19, has recently emerged, and has caused a global pandemic along with an international public health emergency. Currently, no licensed vaccines are available for COVID-19. The identification of immunodominant epitopes for both B- and T-cells that induce protective responses in the host is crucial for effective vaccine design. Computational prediction of potential epitopes might significantly reduce the time required to screen peptide libraries as part of emergent vaccine design. In our present study, we used an extensive immunoinformatics-based approach to predict conserved immunodominant epitopes from the proteome of SARS-CoV-2. Regions from SARS-CoV-2 protein sequences were defined as immunodominant, based on the following three criteria regarding B- and T-cell epitopes: (i) they were both mapped, (ii) they predicted protective antigens, and (iii) they were completely identical to experimentally validated epitopes of SARS-CoV. Further, structural and molecular docking analyses were performed in order to understand the binding interactions of the identified immunodominant epitopes with human major histocompatibility complexes (MHC). Our study provides a set of potential immunodominant epitopes that could enable the generation of both antibody- and cell-mediated immunity. This could contribute to developing peptide vaccine-based adaptive immunotherapy against SARS-CoV-2 infections and prevent future pandemic outbreaks.

15 August 2006 in Biochemistry
Verified
Journal Article
Closed access
NMNina Moor
Nina Moor
OKOlga Kotik-Kogan
Olga Kotik-Kogan
DTDmitry Tworowski
Dmitry Tworowski
MSMaria Sukhanova
Maria Sukhanova
MSMark Safro
Mark Safro